We are live on ! Find out more
IMMP

Immutep

24 hedge funds and large institutions have $692K invested in Immutep in 2026 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 3 increasing their positions, 8 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,367% more call options, than puts

Call options by funds: $74K | Put options by funds: $3K

0% more funds holding

Funds holding: 24 → 24 (0)

0% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 12

0.64% less ownership

Funds ownership: 1.77% → 1.13% (-0.64%)

55% less capital inflows, than outflows

Capital inflows: $295K | Capital outflows: $655K

63% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 8

Holders
24
Holders Change
–
Holders Change %
0%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
3
Reduced
8
Closed
12
Calls
$74K
Puts
$3K
Net Calls
+$71K
Net Calls Change
+$55K

IMMP Hedge Fund Activity: Q2 2026 in Review

24 of the 8,358 institutional investors tracked by Wall St. Rank reported a position in Immutep (IMMP) for Q2 2026, worth a combined $692K — down 24% from $916K a quarter earlier.

Fund positioning in IMMP was balanced in Q2 2026: 12 funds opened new positions, 12 closed out, 3 added to existing stakes and 8 trimmed.

The largest buyer was Vanguard Personalized Indexing Management, opening a new position worth an estimated $156K. The largest seller was UBS Group, cutting an estimated $325K.

  • 24 institutional investors held Immutep (IMMP) as of Q2 2026, unchanged from Q1 2026.
  • Funds reported $692K of Immutep stock for Q2 2026, down 24% quarter-over-quarter.
  • 12 funds opened new Immutep positions in Q2 2026 and 12 closed out, a net change of 0 holders.
  • The largest Immutep buyer in Q2 2026 was Vanguard Personalized Indexing Management, an estimated $156K added.
  • The largest Immutep seller in Q2 2026 was UBS Group, an estimated $325K sold.

Based on aggregated 13F filings for Q2 2026.